$260,000 Awarded to Augment Clinical Trial Program Funding

Share Article

CureSearch for Children’s Cancer announced today the grant recipients of the CureSearch Community Impact Award – Clinical Trials (CCIA-CT), co-funded by Gateway for Cancer Research℠. A combined total of $260,000 will be distributed to thirteen award recipients who are focusing on pilot or early phase (Phase Zero, I or II) clinical trial programs for pediatric cancers.

News Image
Both CureSearch and Gateway understand the importance of clinical trials and want to support the greatest chance for widespread impact for families whose child’s participation promises a better chance for survival.

The thirteen CureSearch Community Impact Awards – Clinical Trials award recipients are:

Pietro Bonacossa
Variety Children's Hospital dba Miami Children's Hospital    
Miami, FL

Kathleen Dorris
The Children's Hospital Association    
Aurora, CO

Jennifer Elster
University of Louisville Research Foundation, Inc.    
Louisville, KY

Adam Green
Regents of the University of Colorado, a body corporate, for and on behalf of the University of Colorado Denver    
Aurora, CO

Leo Mascarenhas
Children's Hospital, Los Angeles     
Los Angeles, CA

Gary Mason
Children's Hospital of Pittsburgh of UPMC    
Pittsburgh, PA

William Petersen
The Rector and Visitors of the University of Virginia    
Charlottesville, VA

Bassem Razzouk
St. Vincent Hospital and Health Care Center, Inc.    
Indianapolis, IN

David Walterhouse
Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, IL

Zhihong Wang
Wayne State University    
Detroit, MI

Brenda Weigel
Regents of the University of Minnesota - Twin Cities    
Minneapolis, MN

Cynthia Wetmore
Children's Healthcare of Atlanta, Inc.
Atlanta, GA

Sarah Whittle
Baylor College of Medicine    
Houston, TX

The CCIA - CT awards opportunity is the result of a new partnership with CureSearch for Children’s Cancer and Gateway for Cancer Research (Gateway) and is intended to support US-based hospitals enrolling patients in pilot or early-phase clinical trials, and augment institutional efforts to administer clinical trials.

“Both CureSearch and Gateway understand the importance of clinical trials and want to support the greatest chance for widespread impact for families whose child’s participation promises a better chance for survival,” said Laura Thrall, chief executive officer of CureSearch for Children’s Cancer.

”Gateway and CureSearch are aligned in our quest to shape a world in which a cancer diagnosis is no longer feared. Through our work to fund innovative and breakthrough cancer clinical trials, we hope to find better options for young patients living with cancer to feel better, live longer and conquer cancer TODAY!” said Teresa Hall Bartels, president of Gateway for Cancer Research.

###

CureSearch for Children’s Cancer
CureSearch for Children’s Cancer, a national nonprofit organization based in Bethesda, Md, works to end childhood cancer by driving targeted and innovative research with measurable results in an accelerated time frame. CureSearch is building a $10 million research pipeline to aggressively drive pediatric research grants and clinical trials that have a higher chance of becoming cures for children’s cancer without the toxic side effects that plague current treatment options.

For more information, visit http://www.curesearch.org, follow us on Twitter @curesearch or join the conversation on Facebook at http://www.facebook.com/curesearch

About Gateway for Cancer Research℠
Gateway for Cancer Research is a nonprofit 501(c)(3) organization committed to funding innovative cancer research studies that help people living with cancer to feel better, live longer and conquer cancer TODAY!. Thanks to generous underwriting by Cancer Treatment Centers of America®, 99 cents of every dollar Gateway receives directly funds phase I and phase II cancer clinical trials at leading research institutions across the country and abroad. Since 1991, Gateway has supported more than 120 clinical trials and funded millions in leading-edge research, including blending the best of conventional and complementary and alternative therapies.

For more information, please visit GatewayCR.org, like us on Facebook at facebook.com/demandcures and join the conversation on Twitter @DemandCures. #BeAGateway.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Victor Young

Laurie Kelly
@DemandCures
Follow >
Gateway for Cancer Research
since: 07/2008
Like >
Visit website

Media